Candel Therapeutics, Inc. (CADL) Ownership

$8.70

south_east
-$0.52 (-5.64%)
Day's range
$8.5
Day's range
$9.4

Candel Therapeutics, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
FMR LLC 02/13/2025 3.92 M $34.06 M   59,592.67% 12.26%
BAKER BROS. ADVISORS LP 02/14/2025 2.98 M $25.88 M   100.00% 9.31%
02/14/2025 1.94 M $16.84 M   100.00% 6.06%
BRAIDWELL LP 02/14/2025 1.60 M $13.89 M   100.00% 5.00%
VANGUARD GROUP INC 02/11/2025 1.34 M $11.62 M   41.52% 4.18%
BLACKROCK FUNDING, INC. /DE 02/07/2025 1.18 M $10.28 M   5.18% 3.70%
PORTOLAN CAPITAL MANAGEMENT, LLC 02/13/2025 753,745 $6.54 M   100.00% 2.35%
HALTER FERGUSON FINANCIAL INC. 02/11/2025 681,334 $5.91 M   123.73% 2.13%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/14/2025 661,500 $5.74 M   2,702.97% 2.07%
STATE STREET CORP 02/14/2025 560,969 $4.87 M   14.02% 1.75%
GEODE CAPITAL MANAGEMENT, LLC 02/12/2025 455,424 $3.95 M   1.43% 1.42%
SANDS CAPITAL VENTURES, LLC 02/13/2025 405,837 $3.52 M   0.00% 1.27%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/14/2025 370,200 $3.21 M   474.84% 1.16%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/14/2025 294,443 $2.56 M   117.37% 0.92%
UBS GROUP AG 02/14/2025 156,806 $1.36 M   1,560.03% 0.49%
HB WEALTH MANAGEMENT, LLC 01/15/2025 87,300 $696,189   54.08% 0.27%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 02/14/2025 77,195 $670,053   -4.22% 0.24%
NUVEEN ASSET MANAGEMENT, LLC 02/14/2025 68,226 $592,202   3.03% 0.21%
GOLDMAN SACHS GROUP INC 02/11/2025 65,236 $566,249   115.58% 0.20%
BIRCHVIEW CAPITAL, LP 02/14/2025 60,000 $520,800   100.00% 0.19%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 02/06/2025 52,190 $453,009   11.57% 0.16%
MAVEN SECURITIES LTD 02/14/2025 51,731 $449,025   100.00% 0.16%
MML INVESTORS SERVICES, LLC 02/13/2025 49,235 $427,000   120.66% 0.15%
BANK OF NEW YORK MELLON CORP 02/04/2025 44,980 $390,425   0.00% 0.14%
COMMONWEALTH EQUITY SERVICES, LLC 02/10/2025 41,098 $357,000   100.00% 0.13%
OPPENHEIMER & CO INC 02/05/2025 37,915 $329,102   100.00% 0.12%
BARCLAYS PLC 02/13/2025 34,317 $297,000   19.62% 0.11%
02/14/2025 32,900 $285,572   100.00% 0.10%
MILLENNIUM MANAGEMENT LLC 02/14/2025 31,626 $274,514   130.64% 0.10%
DEUTSCHE BANK AG\ 02/14/2025 31,522 $273,611   5,814.07% 0.10%
JANE STREET GROUP, LLC 02/14/2025 30,200 $262,136   100.00% 0.09%
HEIGHTS CAPITAL MANAGEMENT, INC 02/14/2025 30,000 $260,400   100.00% 0.09%
RHUMBLINE ADVISERS 01/30/2025 26,272 $228,032   17.00% 0.08%
AQR CAPITAL MANAGEMENT LLC 02/14/2025 21,859 $189,736   9.10% 0.07%
02/14/2025 20,000 $173,600   100.00% 0.06%
SQUAREPOINT OPS LLC 02/14/2025 19,311 $167,619   86.60% 0.06%
VONTOBEL HOLDING LTD. 01/30/2025 19,000 $164,920   -13.64% 0.06%
CITIGROUP INC 02/12/2025 18,603 $161,474   28.39% 0.06%
JANE STREET GROUP, LLC 02/14/2025 16,572 $143,845   -49.47% 0.05%
METLIFE INVESTMENT MANAGEMENT, LLC 02/13/2025 13,773 $119,550   9.68% 0.04%
MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. 02/14/2025 12,165 $105,592   12.38% 0.04%
OXFORD ASSET MANAGEMENT LLP 02/14/2025 12,003 $104,186   100.00% 0.04%
TRANSFORM WEALTH, LLC 01/17/2025 11,577 $100,489   100.00% 0.04%
COREBRIDGE FINANCIAL, INC. 02/11/2025 10,770 $93,484   0.27% 0.03%
ALLIANCEBERNSTEIN L.P. 02/12/2025 10,660 $92,529   0.00% 0.03%
JPMORGAN CHASE & CO 02/12/2025 10,426 $90,498   15.19% 0.03%
WELLS FARGO & COMPANY/MN 02/13/2025 10,122 $87,859   63.60% 0.03%
02/14/2025 6,046 $42,745   100.00% 0.02%
02/11/2025 5,419 $47,037   100.00% 0.02%
SIMPLEX TRADING, LLC 02/11/2025 4,569 $39,000   -79.99% 0.01%

Candel Therapeutics, Inc. institutional Ownership - FAQ's

During the previous two years, 65 institutional investors and hedge funds held shares of Candel Therapeutics, Inc.. The most heavily invested institutionals were:

FMR LLC: 3.92 M

BAKER BROS. ADVISORS LP: 2.98 M

BRAIDWELL LP: 1.6 M

VANGUARD GROUP INC: 1.34 M

BlackRock Funding, Inc. /DE: 1.18 M

Portolan Capital Management, LLC: 753,745

56.00% of Candel Therapeutics, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 18.42 M shares in the last 24 months. This purchase volume represents approximately $160.23 M in transactions.